Orit Lidor - Clal Biotechnology Insider

CBI -- Israel Stock  

ILS 341.80  1.30  0.38%

  VP
We currently do not have informatin regarding Orit Lidor. This executive tanure with Clal Biotechnology Industries Ltd is not currenlty determined.
Age: 35  VP Since 2011      
972 3 612 1616  http://www.cbi.co.il

Management Efficiency

The company has return on total asset (ROA) of (4.59) % which means that it has lost $4.59 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE) of (2.14) % meaning that it generated substantial loss on money invested by shareholders.
The company has accumulated 85.39 M in total debt with debt to equity ratio (D/E) of 10.7 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Clal Biotechnology Industries Ltd has Current Ratio of 3.35 suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due.

Similar Executives

Found 2 records

VP Since

Liliana BarKamada Ltd
2012
Pnina StraussKamada Ltd
2015

Entity Summary

Clal Biotechnology Industries Ltd. is a private equity and venture capital firm specializing in development stage, pre-clinical incubation, seed, start-up, early venture, emerging growth, mid venture, late venture, PIPEs, and growth capital stages of financing. It operates as a subsidiary of Clal Industries and Investments Ltd. Clal Biotechnology operates under Biotechnology classification in Israel and traded on Tel Aviv Stock Exchange.Clal Biotechnology Industries Ltd (CBI) is traded on Tel Aviv Stock Exchange in Israel. It is located in Azrieli Center and employs 14 people.

Clal Biotechnology Leadership Team

Ofer Goldberg, VP
Sigalia Heifetz, Director
Shmuel Rubinstein, External Director
Tomer Babai, Director
Dafna Gruber, Director
Aharon Schwartz, Director
Gavriel Barabash, Director
Isaac Kohlberg, Director
Nofar Malovani, Director
Assaf Segal, CFO
Ofer Gonen, Vice President
Avraham Fischer, Chairman of the Board
Yuval Yanai, External Director
Julian Adams, President Chief Scientific Officer
Orit Lidor, VP and General Counsel

Stock Performance Indicators

Did you try this?

Run Transaction History Now

   

Transaction History

View history of all your transactions and understand their impact on performance
All  Next Launch Transaction History

Clal Biotechnology Pair Correlation

Equities Pair Trading Analysis

Correlation analysis and pair trading evaluation for Clal Biotechnology and Kamada Ltd. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  
Check also Trending Equities. Please also try Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of macroaxis ideas.
Search macroaxis.com